COCH | Envoy Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	1.6400 - 2.0000
52 Week Range	1.0800 - 11.46
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	104,693
Average Volume	244,357
Shares Outstanding	20,244,900
Market Cap	33,404,085
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-04-29

Valuation
Profitability
Growth
Health
P/E Ratio	-1.29
Forward P/E Ratio	N/A
EPS	-1.28
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	34
Country	USA
Website	COCH

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

*Chart delayed

Analyzing fundamentals for COCH we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see COCH Fundamentals page.

Watching at COCH technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on COCH Technicals page.